Senior Regulatory Affairs Advisor

Finn holds an MSc Pharm degree from the Royal Danish School of Pharmacy, University of Copenhagen, Denmark. Finn has more than 30 years’ experience working in the pharmaceutical industry, including senior positions such as Corporate Vice President, Regulatory Affairs Insulins at Novo Nordisk. Over the years, Finn has been responsible for developing and implementing regulatory strategies for all phases of drug development from idea through development to approval and throughout life cycle management and have followed several new drug candidates through to global approval. He has attended multiple agency meetings and negotiated with regulatory authorities globally, including Oral Explanations in EU and Advisory Committee meetings in the US.